Bausch + Lomb Co. (NYSE:BLCO) receives consensus rating of “Moderate Buy” from the brokerage

Bausch + Lomb Co. (NYSE:BLCO – Get Your Free Report ) has been given an average recommendation of “Moderate Buy” by the twelve brokerages that are presently covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $18.59.

A number of research analysts have weighed in on BLCO shares. Needham & Company LLC restated a “hold” rating on shares of Bausch + Lomb in a report on Thursday, August 1st. HC Wainwright decreased their price objective on shares of Bausch + Lomb from $20.00 to $19.00 and set a “buy” rating on the stock in a report on Monday, August 5th. Raymond James assumed coverage on Bausch + Lomb in a research note on Wednesday, July 10th. They set an “outperform” rating and a $19.00 price target for the company. Royal Bank of Canada reissued an “outperform” rating and issued a $20.00 target price on shares of Bausch + Lomb in a report on Thursday, August 1st. Finally, Evercore ISI upped their target price on shares of Bausch + Lomb from $15.00 to $15.50 and gave the stock an “in-line” rating in a research report on Tuesday, 2 July.

Get the latest analysis on Bausch + Lomb

Insiders place their bets

In related news, CEO Brent L. Saunders purchased 32,250 shares of the business’s stock in a transaction on Monday, August 5th. The shares were bought at an average cost of $15.66 per share, with a total value of $505,035.00. Following the completion of the acquisition, the chief executive officer now owns 595,169 shares in the company, valued at approximately $9,320,346.54. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available via this link.

Institutional investors weigh in on Bausch + Lomb

Large investors have recently bought and sold shares of the stock. Jump Financial LLC raised its holdings in Bausch + Lomb by 478.0% in the fourth quarter. Jump Financial LLC now owns 87,100 shares of the company’s stock worth $1,486,000 after acquiring an additional 72,030 shares during the period. Brandes Investment Partners LP boosted its holdings in shares of Bausch + Lomb by 11.0% in the fourth quarter. Brandes Investment Partners LP now owns 114,200 shares of the company’s stock valued at $1,948,000 after purchasing an additional 11,321 shares in the last quarter. Allianz Asset Management GmbH purchased a new stake in Bausch + Lomb during the fourth quarter valued at about $1,706,000. Gabelli Funds LLC boosted its holdings in shares of Bausch + Lomb by 14.5% in the fourth quarter. Gabelli Funds LLC now owns 302,000 shares of the company’s stock worth $5,152,000 after buying an additional 38,256 shares during the period. Finally, Freshford Capital Management LLC boosted its holdings in shares of Bausch + Lomb by 29.8% in the fourth quarter. Freshford Capital Management LLC now owns 1,754,123 shares of the company’s stock valued at $29,925,000 after buying an additional 403,062 shares in the last quarter. Institutional investors and hedge funds own 11.07% of the company’s shares.

Bausch + Lomb price performance

Shares of NYSE BLCO stock opened at $16.43 on Monday. Bausch + Lomb has a fifty-two week low of $13.16 and a fifty-two week high of $18.51. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.01, and a current ratio of 1.65. The company has a market cap of $5.78 billion, a PE ratio of -17.11, a P/E/G ratio of 1.53 and a beta of 0.47. The company has a 50 day simple moving average of $15.84 and a two hundred day simple moving average of $15.60.

Bausch + Lomb (NYSE:BLCO – Get Your Free Report ) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.13 EPS for the quarter, meeting the consensus estimate of $0.13. Bausch + Lomb had a negative net margin of 10.15% and a positive return on equity of 3.36%. The company had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.17 billion. In the same period last year, the company earned $0.18 per share. The company’s revenues increased by 17.5% year-on-year. As a group, equities analysts expect Bausch + Lomb to post 0.6 EPS for the current fiscal year.

About Bausch + Lomb

(Get a free report

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea and internationally. It operates in three segments: Vision Care, Pharmaceuticals and Surgical. The Vision Care segment offers contact lenses that cover the spectrum of wear patterns, including daily disposable and frequently replaced contact lenses; and contact lens care products that include over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions such as eye allergies, conjunctivitis, dry eye, and redness relief.

See Also

Get news and reviews for Bausch + Lomb daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bausch + Lomb and related companies with MarketBeat.com’s FREE daily email newsletter.